首页 > 最新文献

Acta neurologica Taiwanica最新文献

英文 中文
Macrophage Activation Syndrome in a Case of Myasthenia Gravis with Concurrent Cytomegalovirus Infection. 巨噬细胞激活综合征并发巨细胞病毒感染重症肌无力1例。
Q3 Medicine Pub Date : 2020-12-01
Nai-Hsin Huang, Li-Ming Lien, Wen-Hung Chen

Objective: Macrophage activation syndrome (MAS) or reactive hemophagocytic lymphohistiocytosis (HLH) refers to a set of clinical symptoms caused by the excessive activation and proliferation of macrophages. It was linked with autoimmune disease such as systemic-onset juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatoid arthritis, and dermatomyositis, etc. Herein we report a case of myasthenia gravis (MG) with concurrent cytomegalovirus (CMV) infection developed MAS.

Case report: A 31-year-old female with history of MG for 2 years under stable control with azathioprine and prednisolone. She presented with persistent high fever for 2 weeks after an upper respiratory infection. Lab data revealed pancytopenia, elevated triglyceride, ferritin and C-reactive protein (CRP). A bone marrow aspiration confirmed hemophagocytosis. Investigation for occult infection revealed her plasma was positive for CMV IgG and IgM, and high for CMV viral load. She was then treated with 5 sessions of plasmapheresis and pulse steroid. Azathioprine was discontinued and replaced with cyclosporine. Gancylovir was given for her concurrent CMV infection. After 2 weeks of treatment, her fever gradually subsided, and her blood cell count, hepatobiliary enzymes, ferritin and CRP have returned to normal range. She was discharged in good recovery.

Conclusion: MAS is a rare complication of systemic autoimmune disease with poor prognosis, which may be precipitated by concurrent infection. Early recognition of this syndrome and prompt immune modulation therapy is crucial for successful treatment.

目的:巨噬细胞活化综合征(Macrophage activation syndrome, MAS)或反应性噬血细胞淋巴组织细胞增生症(reactive hemophagocytic lymphohistiocytosis, HLH)是指巨噬细胞过度活化和增殖引起的一组临床症状。它与自身免疫性疾病有关,如全身性幼年类风湿性关节炎、系统性红斑狼疮、类风湿性关节炎和皮肌炎等。在此,我们报告一例合并巨细胞病毒(CMV)感染的重症肌无力。病例报告:31岁女性,MG病史2年,用硫唑嘌呤和泼尼松龙稳定控制。上呼吸道感染后持续高热2周。实验室数据显示全血细胞减少、甘油三酯、铁蛋白和c反应蛋白(CRP)升高。骨髓穿刺证实有噬血细胞症。隐匿性感染调查显示其血浆巨细胞病毒IgG和IgM阳性,巨细胞病毒载量高。随后给予5次血浆置换和脉冲类固醇治疗。停用硫唑嘌呤,代之以环孢素。同时感染巨细胞病毒给予更昔洛韦治疗。治疗2周后,患者发热逐渐消退,血细胞计数、肝胆酶、铁蛋白、CRP恢复正常。她出院时恢复良好。结论:MAS是一种罕见的系统性自身免疫性疾病并发症,预后较差,可能由并发感染诱发。早期识别这种综合征并及时进行免疫调节治疗是成功治疗的关键。
{"title":"Macrophage Activation Syndrome in a Case of Myasthenia Gravis with Concurrent Cytomegalovirus Infection.","authors":"Nai-Hsin Huang,&nbsp;Li-Ming Lien,&nbsp;Wen-Hung Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Macrophage activation syndrome (MAS) or reactive hemophagocytic lymphohistiocytosis (HLH) refers to a set of clinical symptoms caused by the excessive activation and proliferation of macrophages. It was linked with autoimmune disease such as systemic-onset juvenile rheumatoid arthritis, systemic lupus erythematosus, rheumatoid arthritis, and dermatomyositis, etc. Herein we report a case of myasthenia gravis (MG) with concurrent cytomegalovirus (CMV) infection developed MAS.</p><p><strong>Case report: </strong>A 31-year-old female with history of MG for 2 years under stable control with azathioprine and prednisolone. She presented with persistent high fever for 2 weeks after an upper respiratory infection. Lab data revealed pancytopenia, elevated triglyceride, ferritin and C-reactive protein (CRP). A bone marrow aspiration confirmed hemophagocytosis. Investigation for occult infection revealed her plasma was positive for CMV IgG and IgM, and high for CMV viral load. She was then treated with 5 sessions of plasmapheresis and pulse steroid. Azathioprine was discontinued and replaced with cyclosporine. Gancylovir was given for her concurrent CMV infection. After 2 weeks of treatment, her fever gradually subsided, and her blood cell count, hepatobiliary enzymes, ferritin and CRP have returned to normal range. She was discharged in good recovery.</p><p><strong>Conclusion: </strong>MAS is a rare complication of systemic autoimmune disease with poor prognosis, which may be precipitated by concurrent infection. Early recognition of this syndrome and prompt immune modulation therapy is crucial for successful treatment.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(4) ","pages":"114-118"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39017270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significant Destructive Interaction of BDNF Val>Met Polymorphism with Stroke Severity and Family History of Dementia for Cognitive Impairments. BDNF Val>Met多态性与脑卒中严重程度和认知障碍痴呆家族史的显著破坏性相互作用
Q3 Medicine Pub Date : 2020-09-30
Sajjad Rezaei, Karim Asgari Mobarake, Alia Saberi, Parvaneh Keshavarz

Purpose: The patients with more severe stroke, have more chance to develop higher levels of cognitive impairments; and family history of dementia as a genetic background, can give rise to an increased risk of the severity of cognitive deterioration. In this study, we sought to investigate whether the risk alleles of Val66Met of brain-derived neurotrophic factor (BDNF) polymorphism, has a destructive interaction with the stroke severity (SS) and family history of dementia (FHD) for cognitive impairments?

Method: In a case-control study, the carriers of at least one Val allele (n=56) were compared to the carriers of Met/Met homozygotes (n=156) in terms of FHD and SS (through National Institutes of Health Stroke Scale) on the north of Iran. To determine the cognitive functions, the third version of Addenbrooke's Cognitive Examination (ACE-III) was used.

Result: The mean age of patients was 64.52±11.71, and in average 202 day had passed from their stroke. The interactive effects of genotypes Val66Met BDNF with SS[F=8.95, ή2=0.04, P=0.003] and FHD[F=4.59, ή2=0.02, P=0.03] were significant for total score of ACE-III. It means that the Met/ Met homozygosity, modulated the effect of risk factors of SS and FHD on the cognitive function. Such homozygosity protects the attentional function and language abilities against the SS and FHD(P≤0.05).

Conclusion: It can be speculated that presence of Val/Met heterozygosity has a destructive interaction with the SS and FHD for decreasing the cognitive function, particularly in attention and language domains. Our findings suggested that the inhibition of signaling and trafficking of Val/Met heterozygosity is possibly a practical strategy in reducing the cognitive impairments following the stroke.

目的:脑卒中越严重,患者发生认知功能障碍的可能性越大;而痴呆家族史作为遗传背景,会增加认知能力恶化严重程度的风险。在这项研究中,我们试图调查脑源性神经营养因子(BDNF)多态性的风险等位基因Val66Met是否与脑卒中严重程度(SS)和认知障碍痴呆家族史(FHD)具有破坏性相互作用?方法:在一项病例对照研究中,将伊朗北部至少一个Val等位基因携带者(n=56)与Met/Met纯合子携带者(n=156)在FHD和SS方面进行比较(通过国家卫生研究院卒中量表)。采用第三版阿登布鲁克认知测验(ACE-III)测定认知功能。结果:患者平均年龄为64.52±11.71岁,卒中时间平均为202 d。基因型Val66Met BDNF与SS[F=8.95,串联串联记录法2=0.04,P=0.003]和FHD[F=4.59,串联串联串联记录法2=0.02,P=0.03]的交互作用对ACE-III总分有显著影响。说明Met/ Met纯合性调节了SS和FHD危险因素对认知功能的影响。这种纯合性对SS和FHD的注意功能和语言能力有保护作用(P≤0.05)。结论:可以推测Val/Met杂合性的存在与SS和FHD具有破坏性的相互作用,从而降低认知功能,特别是在注意和语言领域。我们的研究结果表明,抑制Val/Met杂合性的信号传导和运输可能是减少中风后认知障碍的一种实用策略。
{"title":"Significant Destructive Interaction of BDNF Val>Met Polymorphism with Stroke Severity and Family History of Dementia for Cognitive Impairments.","authors":"Sajjad Rezaei,&nbsp;Karim Asgari Mobarake,&nbsp;Alia Saberi,&nbsp;Parvaneh Keshavarz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The patients with more severe stroke, have more chance to develop higher levels of cognitive impairments; and family history of dementia as a genetic background, can give rise to an increased risk of the severity of cognitive deterioration. In this study, we sought to investigate whether the risk alleles of Val66Met of brain-derived neurotrophic factor (BDNF) polymorphism, has a destructive interaction with the stroke severity (SS) and family history of dementia (FHD) for cognitive impairments?</p><p><strong>Method: </strong>In a case-control study, the carriers of at least one Val allele (n=56) were compared to the carriers of Met/Met homozygotes (n=156) in terms of FHD and SS (through National Institutes of Health Stroke Scale) on the north of Iran. To determine the cognitive functions, the third version of Addenbrooke's Cognitive Examination (ACE-III) was used.</p><p><strong>Result: </strong>The mean age of patients was 64.52±11.71, and in average 202 day had passed from their stroke. The interactive effects of genotypes Val66Met BDNF with SS[F=8.95, ή2=0.04, P=0.003] and FHD[F=4.59, ή2=0.02, P=0.03] were significant for total score of ACE-III. It means that the Met/ Met homozygosity, modulated the effect of risk factors of SS and FHD on the cognitive function. Such homozygosity protects the attentional function and language abilities against the SS and FHD(P≤0.05).</p><p><strong>Conclusion: </strong>It can be speculated that presence of Val/Met heterozygosity has a destructive interaction with the SS and FHD for decreasing the cognitive function, particularly in attention and language domains. Our findings suggested that the inhibition of signaling and trafficking of Val/Met heterozygosity is possibly a practical strategy in reducing the cognitive impairments following the stroke.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(3) ","pages":"67-78"},"PeriodicalIF":0.0,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wernekink Commissure Syndrome: A Rare Cause of Bilateral Cerebellar Syndrome. Wernekink连接综合征:双侧小脑综合征的罕见病因。
Q3 Medicine Pub Date : 2020-09-01
Kefah Alhayek, Belal Aldabbour, Haneen Al Refa'I Refa'I, Maram Alanbar

Purpose: Focal signs are a big deal in neurology and are among the most important clues leading to diagnosis and localization. Wernekink commissure syndrome is due to lesions in the caudal paramedian midbrain involving the entire decussation of the superior cerebellar peduncles, resulting in the clinical hallmark of a bilateral cerebellar syndrome.

Case report: A 79-year-old man presented with sudden, severe unsteadiness associated with slurring of speech, binocular double vision, and bilateral hand tremor. Examination showed right INO, moderately severe dysarthria, bilateral dysmetria and dysdiadochokinesia, with severe truncal ataxia and bilateral upper and lower limb ataxia. Also, bilateral coarse tremor was noted in both hands which was present at rest, action and on reaching for objects. Brain MRI revealed an acute infarction involving the Wernekinck decussation in the right caudal midbrain and mesencephalo-pontine junction.

Conclusion: The differential of Wernekink Commissure Syndrome is complex, and localization and lateralization are extremely difficult owing to prominent bilateral cerebellar symptoms. The finding of an associated unilateral INO in some cases makes it possible to confidently narrow the list of differentials and localize the lesion to the paramedian tegmentum ipsilateral to the non-adducting eye.

目的:局灶性征象在神经学中是很重要的,是诊断和定位的最重要的线索之一。Wernekink连接综合征是由于尾端中脑旁正中部病变累及整个小脑上脚,导致双侧小脑综合征的临床标志。病例报告:一名79岁男性,表现为突然,严重的不稳定,伴有言语不清,双眼复视和双侧手震颤。检查示右侧肌无力,中重度构音障碍,双侧构音障碍及运动障碍,伴严重的躯干共济失调及双侧上下肢共济失调。此外,在休息、行动和伸手拿东西时,双侧双手都有粗糙的震颤。脑MRI显示急性梗死涉及Wernekinck讨论在右侧尾侧中脑和中脑-桥脑交界处。结论:Wernekink连接综合征的鉴别复杂,由于双侧小脑症状突出,定位和侧化极为困难。在一些病例中发现相关的单侧内陷,可以自信地缩小鉴别列表,并将病变定位于非内收眼的同侧旁正中被盖。
{"title":"Wernekink Commissure Syndrome: A Rare Cause of Bilateral Cerebellar Syndrome.","authors":"Kefah Alhayek,&nbsp;Belal Aldabbour,&nbsp;Haneen Al Refa'I Refa'I,&nbsp;Maram Alanbar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Focal signs are a big deal in neurology and are among the most important clues leading to diagnosis and localization. Wernekink commissure syndrome is due to lesions in the caudal paramedian midbrain involving the entire decussation of the superior cerebellar peduncles, resulting in the clinical hallmark of a bilateral cerebellar syndrome.</p><p><strong>Case report: </strong>A 79-year-old man presented with sudden, severe unsteadiness associated with slurring of speech, binocular double vision, and bilateral hand tremor. Examination showed right INO, moderately severe dysarthria, bilateral dysmetria and dysdiadochokinesia, with severe truncal ataxia and bilateral upper and lower limb ataxia. Also, bilateral coarse tremor was noted in both hands which was present at rest, action and on reaching for objects. Brain MRI revealed an acute infarction involving the Wernekinck decussation in the right caudal midbrain and mesencephalo-pontine junction.</p><p><strong>Conclusion: </strong>The differential of Wernekink Commissure Syndrome is complex, and localization and lateralization are extremely difficult owing to prominent bilateral cerebellar symptoms. The finding of an associated unilateral INO in some cases makes it possible to confidently narrow the list of differentials and localize the lesion to the paramedian tegmentum ipsilateral to the non-adducting eye.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(3) ","pages":"86-89"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a. 干扰素β-1a治疗严重坏死和蜂窝织炎。
Q3 Medicine Pub Date : 2020-09-01
Chun-Chen Chang, Chien-Hui Lin, Jen-Jen Su

Purpose: A case report with a review of the current literature concerning cutaneous necrosis has occasionally been reported in interferon therapy.

Case report: We report a 19-year-old woman diagnosed multiple sclerosis for three years. She selfinjected the standard dose of recombinant interferonβ-1a (12 million units) subcutaneously three times a week. Severe necrotizing cutaneous reactions over abdomen Happened and she must receive parental antibiotics and surgical debridement.

Conclusion: Our observation emphasizes the importance of educating patients on the proper selfadministration of subcutaneous injections of interferon β.

目的:一个病例报告,并回顾目前的文献有关皮肤坏死偶有报道在干扰素治疗。病例报告:我们报告一个19岁的女性诊断多发性硬化症三年。她每周皮下注射三次标准剂量的重组干扰素β-1a(1200万单位)。腹部发生了严重的皮肤坏死性反应,必须接受父母抗生素治疗和手术清创。结论:我们的观察强调了教育患者正确皮下注射干扰素β的重要性。
{"title":"Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a.","authors":"Chun-Chen Chang,&nbsp;Chien-Hui Lin,&nbsp;Jen-Jen Su","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>A case report with a review of the current literature concerning cutaneous necrosis has occasionally been reported in interferon therapy.</p><p><strong>Case report: </strong>We report a 19-year-old woman diagnosed multiple sclerosis for three years. She selfinjected the standard dose of recombinant interferonβ-1a (12 million units) subcutaneously three times a week. Severe necrotizing cutaneous reactions over abdomen Happened and she must receive parental antibiotics and surgical debridement.</p><p><strong>Conclusion: </strong>Our observation emphasizes the importance of educating patients on the proper selfadministration of subcutaneous injections of interferon β.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(3) ","pages":"90-94"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mathematical Framework of Deconvolution Algorithms for Quantification of Perfusion Parameters. 灌注参数定量反卷积算法的数学框架。
Q3 Medicine Pub Date : 2020-09-01
Fanpei Yang, Sukhdeep Singh Bal Bal, Yueh-Feng Sung, Giia-Sheun Peng

Purpose: MR perfusion weighted imaging (PWI) has been used as sensitive indicator of tissue at risk for infarction. Quantitative perfusion parameters such as cerebral blood flow (CBF), mean transit time (MTT) and cerebral blood volume (CBV) can be obtained from post processing of PWI data using standard singular value decomposition algorithm (SVD). Assumption regarding absence of arterial - tissue delay (ATD) used in SVD algorithm results in underestimation of perfusion parameters. To estimate accurate values for perfusion parameters it is important to understand the mathematical framework behind SVD and improved SVD algorithms (bSVD and rSVD).

Method: This study explains the mathematical framework of SVD and improved SVD algorithms and uses computational techniques that use bSVD algorithm to obtain perfusion parameters maps of CBF, CBV and MTT for acute stroke patient.

Result: Computational techniques based on mathematical deconvolution algorithms are used to post process CBV, CBF and MTT maps where decrease in CBF and CBV were seen in left hemisphere.

Conclusion: The bSVD algorithm is found to be sensitive to ATD and provides more accurate estimates of perfusion parameters than the SVD algorithm, however CBF estimates from bSVD and rSVD still remain influenced by other artifacts Keywords: PWI = perfusion weighted imaging, CBF= cerebral blood flow, MTT = mean transit time, CBV= cerebral blood volume, SVD = singular value decomposition algorithm.

目的:磁共振灌注加权成像(PWI)作为梗死危险组织的敏感指标。采用标准奇异值分解算法(SVD)对PWI数据进行后处理,得到脑血流量(CBF)、平均传递时间(MTT)、脑血容量(CBV)等定量灌注参数。SVD算法中采用的动脉组织延迟(ATD)不存在的假设导致了灌注参数的低估。为了准确估计灌注参数值,了解SVD和改进的SVD算法(bSVD和rSVD)背后的数学框架是很重要的。方法:本研究解释了SVD的数学框架和改进的SVD算法,并利用计算技术,利用bSVD算法获得急性脑卒中患者的CBF、CBV和MTT灌注参数图。结果:基于数学反卷积算法的计算技术用于后处理CBV, CBF和MTT图,其中左半球CBF和CBV减少。结论:bSVD算法对ATD敏感,比SVD算法提供更准确的灌注参数估计,但bSVD和rSVD估计的CBF仍受其他伪影的影响。关键词:PWI =灌注加权成像,CBF=脑血流量,MTT =平均传递时间,CBV=脑血容量,SVD =奇异值分解算法。
{"title":"Mathematical Framework of Deconvolution Algorithms for Quantification of Perfusion Parameters.","authors":"Fanpei Yang,&nbsp;Sukhdeep Singh Bal Bal,&nbsp;Yueh-Feng Sung,&nbsp;Giia-Sheun Peng","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>MR perfusion weighted imaging (PWI) has been used as sensitive indicator of tissue at risk for infarction. Quantitative perfusion parameters such as cerebral blood flow (CBF), mean transit time (MTT) and cerebral blood volume (CBV) can be obtained from post processing of PWI data using standard singular value decomposition algorithm (SVD). Assumption regarding absence of arterial - tissue delay (ATD) used in SVD algorithm results in underestimation of perfusion parameters. To estimate accurate values for perfusion parameters it is important to understand the mathematical framework behind SVD and improved SVD algorithms (bSVD and rSVD).</p><p><strong>Method: </strong>This study explains the mathematical framework of SVD and improved SVD algorithms and uses computational techniques that use bSVD algorithm to obtain perfusion parameters maps of CBF, CBV and MTT for acute stroke patient.</p><p><strong>Result: </strong>Computational techniques based on mathematical deconvolution algorithms are used to post process CBV, CBF and MTT maps where decrease in CBF and CBV were seen in left hemisphere.</p><p><strong>Conclusion: </strong>The bSVD algorithm is found to be sensitive to ATD and provides more accurate estimates of perfusion parameters than the SVD algorithm, however CBF estimates from bSVD and rSVD still remain influenced by other artifacts Keywords: PWI = perfusion weighted imaging, CBF= cerebral blood flow, MTT = mean transit time, CBV= cerebral blood volume, SVD = singular value decomposition algorithm.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(3) ","pages":"79-85"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Spinal Cord Infarction: A Prolonged and Stuttering Course for Six Days. 非典型脊髓梗塞:一个延长和口吃的过程,为期6天。
Q3 Medicine Pub Date : 2020-09-01
Meng-Chi Chiu, Chi-Yuan Liang, Yung-Sung Huang, Wen-Long Tsao

Purpose: Spinal infarction is a rare condition and usually presents with a sudden or acute course. A prolonged course is rare and may mimic the presentation of inflammatory myelitis. Here we present a case of atypical spinal cord infarction with a stuttering course for six days..

Case report: A 47-year-old male presented initially with symptoms of sudden onset, limb pain. Sudden chest pain radiating to the back, occurred three days later. Sudden urinary retention and quadriparesis were presented after another three days. The diagnosis of spinal cord infarction was made through diffusion restriction in spinal magnetic resonance imaging.

Conclusion: A prolonged course of spinal cord infarction is relatively uncommon but a stepwise and stuttering course may provide clues. Diffusion restriction in magnetic resonance imaging also may be helpful. The diagnosis of spinal cord infarction should always be kept in mind.

目的:脊髓梗死是一种罕见的疾病,通常表现为突然或急性病程。病程延长是罕见的,可能类似于炎性脊髓炎的表现。我们在此报告一例非典型脊髓梗死伴6天口吃的病例。病例报告:一名47岁男性,最初表现为突然发作的肢体疼痛。三天后突然胸痛放射到背部。3天后出现突发性尿潴留和四肢瘫。脊髓磁共振成像通过扩散限制诊断脊髓梗死。结论:脊髓梗死病程延长相对少见,但逐步结巴病程可能提供线索。磁共振成像中的扩散限制也可能有所帮助。脊髓梗塞的诊断应始终牢记在心。
{"title":"Atypical Spinal Cord Infarction: A Prolonged and Stuttering Course for Six Days.","authors":"Meng-Chi Chiu,&nbsp;Chi-Yuan Liang,&nbsp;Yung-Sung Huang,&nbsp;Wen-Long Tsao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Spinal infarction is a rare condition and usually presents with a sudden or acute course. A prolonged course is rare and may mimic the presentation of inflammatory myelitis. Here we present a case of atypical spinal cord infarction with a stuttering course for six days..</p><p><strong>Case report: </strong>A 47-year-old male presented initially with symptoms of sudden onset, limb pain. Sudden chest pain radiating to the back, occurred three days later. Sudden urinary retention and quadriparesis were presented after another three days. The diagnosis of spinal cord infarction was made through diffusion restriction in spinal magnetic resonance imaging.</p><p><strong>Conclusion: </strong>A prolonged course of spinal cord infarction is relatively uncommon but a stepwise and stuttering course may provide clues. Diffusion restriction in magnetic resonance imaging also may be helpful. The diagnosis of spinal cord infarction should always be kept in mind.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(3) ","pages":"95-98"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38437101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the Demographic and Clinical Profile in a Neurocutaneous Rare Disease: A Cross-Sectional Study. 一种神经皮肤罕见疾病的人口学和临床特征研究:一项横断面研究。
Q3 Medicine Pub Date : 2020-08-01 DOI: 10.21203/rs.3.rs-45681/v1
L. Jouybari, S. Foji, A. Sanagoo, Morteza oladenabidozin, Alireza Yazdani
OBJECTIVENeurofibromatosis is one of the most common dominantly inherited genetic disorders. This study aimed to study the demographic and clinical profile of neurofibromatosis patients.METHODSThis study is cross-sectional conducted in 2020 on the population of patients with neurofibromatosis. Patients who are members of the Neurofibromatosis Association answered the online demographic and clinical information questionnaire.RESULTS446 patients with neurofibromatosis participated in this study with a mean age of 33.39 plus or minus 12.87 years. 297 patients (66.6%) were women and 378 (84.8%) patients had type 1 neurofibromatosis. The disease visibility was reported to be moderate in 254 patients (54.9%) and the severity of the disease was mild in 238 (53.4%) patients. The type of neurofibromatosis was not significantly related to gender, age groups, parental education, and ethnicity. The relationship between severity and age (p is equal to less than 0.001) and gender (p is equal to 0.042) was significant and the relationship between visibility and age (p is equal to less than 0.001) was significant but despite the fact that the disease was more visible in men than women, it was not significantly related to gender.CONCLUSIONSThe study results showed that the most common complication in the study population was Cafe au lait spot. In addition, visibility and severity of the disease were mild and moderate, respectively. Keyword: Neurofibromatosis, Demographic information, Clinical Information.
目的神经纤维瘤病是最常见的显性遗传疾病之一。本研究旨在研究神经纤维瘤病患者的人口统计学和临床特征。方法:本研究于2020年对神经纤维瘤病患者进行横断面研究。神经纤维瘤病协会成员的患者回答了在线人口统计和临床信息问卷。结果446例神经纤维瘤病患者参加了本研究,平均年龄33.39±12.87岁。女性297例(66.6%),1型神经纤维瘤病378例(84.8%)。254例(54.9%)患者的疾病可见性为中度,238例(53.4%)患者的疾病严重程度为轻度。神经纤维瘤病的类型与性别、年龄组、父母教育程度和种族无显著相关。严重程度与年龄(p =小于0.001)和性别(p = 0.042)之间的关系显著,可见性与年龄(p =小于0.001)之间的关系显著,但尽管该疾病在男性中比女性更明显,但与性别无关。结论研究人群中最常见的并发症为咖啡斑。此外,疾病的可见度和严重程度分别为轻度和中度。关键词:神经纤维瘤病,人口学信息,临床信息。
{"title":"Study of the Demographic and Clinical Profile in a Neurocutaneous Rare Disease: A Cross-Sectional Study.","authors":"L. Jouybari, S. Foji, A. Sanagoo, Morteza oladenabidozin, Alireza Yazdani","doi":"10.21203/rs.3.rs-45681/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-45681/v1","url":null,"abstract":"OBJECTIVE\u0000Neurofibromatosis is one of the most common dominantly inherited genetic disorders. This study aimed to study the demographic and clinical profile of neurofibromatosis patients.\u0000\u0000\u0000METHODS\u0000This study is cross-sectional conducted in 2020 on the population of patients with neurofibromatosis. Patients who are members of the Neurofibromatosis Association answered the online demographic and clinical information questionnaire.\u0000\u0000\u0000RESULTS\u0000446 patients with neurofibromatosis participated in this study with a mean age of 33.39 plus or minus 12.87 years. 297 patients (66.6%) were women and 378 (84.8%) patients had type 1 neurofibromatosis. The disease visibility was reported to be moderate in 254 patients (54.9%) and the severity of the disease was mild in 238 (53.4%) patients. The type of neurofibromatosis was not significantly related to gender, age groups, parental education, and ethnicity. The relationship between severity and age (p is equal to less than 0.001) and gender (p is equal to 0.042) was significant and the relationship between visibility and age (p is equal to less than 0.001) was significant but despite the fact that the disease was more visible in men than women, it was not significantly related to gender.\u0000\u0000\u0000CONCLUSIONS\u0000The study results showed that the most common complication in the study population was Cafe au lait spot. In addition, visibility and severity of the disease were mild and moderate, respectively. Keyword: Neurofibromatosis, Demographic information, Clinical Information.","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"70 1","pages":"15-23"},"PeriodicalIF":0.0,"publicationDate":"2020-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85554537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Apilarnil: A Novel Neuroprotective Candidate. 阿非拉尼尔:一种新的神经保护候选者。
Q3 Medicine Pub Date : 2020-06-30
Mehmet Hamamci, Zuleyha Doganyigit, Sibel Silici, Aslı Okan, Emin Kaymak, Seher Yilmaz, Adem Tokpinar, Levent Ertuğrul Inan

Purpose: This study was designed to investigate the effect of apilarnil on neuronal damage and related mechanisms in a sepsis model in order to demonstrate whether or not apilarnil has neuroprotective effect.

Methods: In this study, 64 adult male Sprague-Dawley species rats were randomly divided into eight groups. The rats were administered apilarnil and/or lipopolysaccharide (LPS). Superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), xanthine oxidase (XOD) and testican-1 levels were measured in the brain tissue. Proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin 1 beta [IL-1β], interleukin 6 [IL-6]) were measured in brain tissue. Histological examinations were performed on hippocampus and cortex tissues in all groups. Apoptotic cell count was estimated using the Tunel method to observe the apilarnil's effect on apoptosis. Purkinje cells were counted in the hippocampus to measure the protective effect of apilarnil on the hippocampus.

Results: Apilarnil reduced the decrease in SOD and CAT levels in the brain developing sepsis. Apilarnil reduced the increase in MDA, XOD, and testican-1 levels in the septic brain. It was observed that the number of degenerated neurons due to sepsis decreased as apilarnil dose increased. Apilarnil reduced the elevated levels of proinflammatory cytokines (IL-6, TNF-α, IL-1β) induced by sepsis. Apilarnil prevented sepsis-related apoptosis in the brain.

Conclusion: The neuroprotective potential of apilarnil against brain damage in the sepsis model was demonstrated and suggested that it has the potential to contribute to new therapeutic targets against various neurological disorders.

目的:在脓毒症模型中研究阿匹尼尔对神经元损伤的影响及其机制,以证明阿匹尼尔是否具有神经保护作用。方法:将64只成年雄性Sprague-Dawley大鼠随机分为8组。大鼠给予阿匹尼尔和/或脂多糖(LPS)。测定脑组织超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、丙二醛(MDA)、黄嘌呤氧化酶(XOD)和睾丸素-1水平。检测脑组织促炎因子(肿瘤坏死因子α [TNF-α]、白细胞介素1β [IL-1β]、白细胞介素6 [IL-6])。各组海马和皮质组织均行组织学检查。采用Tunel法测定凋亡细胞数,观察阿匹尼尔对细胞凋亡的影响。计数海马浦肯野细胞,测定阿匹尼尔对海马的保护作用。结果:阿非拉尼尔能降低脓毒症大鼠脑组织中SOD和CAT水平的下降。阿匹拉尼尔降低了脓毒症脑组织中MDA、XOD和睾丸素-1水平的升高。我们观察到,随着阿匹尼尔剂量的增加,脓毒症引起的退行性神经元数量减少。阿哌尼尔降低败血症引起的促炎细胞因子(IL-6、TNF-α、IL-1β)水平升高。阿匹拉尼尔可预防败血症相关的脑细胞凋亡。结论:阿匹拉尼尔对脓毒症模型脑损伤的神经保护作用得到证实,表明它有可能为多种神经系统疾病的治疗提供新的靶点。
{"title":"Apilarnil: A Novel Neuroprotective Candidate.","authors":"Mehmet Hamamci,&nbsp;Zuleyha Doganyigit,&nbsp;Sibel Silici,&nbsp;Aslı Okan,&nbsp;Emin Kaymak,&nbsp;Seher Yilmaz,&nbsp;Adem Tokpinar,&nbsp;Levent Ertuğrul Inan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to investigate the effect of apilarnil on neuronal damage and related mechanisms in a sepsis model in order to demonstrate whether or not apilarnil has neuroprotective effect.</p><p><strong>Methods: </strong>In this study, 64 adult male Sprague-Dawley species rats were randomly divided into eight groups. The rats were administered apilarnil and/or lipopolysaccharide (LPS). Superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), xanthine oxidase (XOD) and testican-1 levels were measured in the brain tissue. Proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin 1 beta [IL-1β], interleukin 6 [IL-6]) were measured in brain tissue. Histological examinations were performed on hippocampus and cortex tissues in all groups. Apoptotic cell count was estimated using the Tunel method to observe the apilarnil's effect on apoptosis. Purkinje cells were counted in the hippocampus to measure the protective effect of apilarnil on the hippocampus.</p><p><strong>Results: </strong>Apilarnil reduced the decrease in SOD and CAT levels in the brain developing sepsis. Apilarnil reduced the increase in MDA, XOD, and testican-1 levels in the septic brain. It was observed that the number of degenerated neurons due to sepsis decreased as apilarnil dose increased. Apilarnil reduced the elevated levels of proinflammatory cytokines (IL-6, TNF-α, IL-1β) induced by sepsis. Apilarnil prevented sepsis-related apoptosis in the brain.</p><p><strong>Conclusion: </strong>The neuroprotective potential of apilarnil against brain damage in the sepsis model was demonstrated and suggested that it has the potential to contribute to new therapeutic targets against various neurological disorders.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(2) ","pages":"33-45"},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37959035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Early Recognition of Treatment Failure and Changing Anti-Epilepsy Medication Regimen Improve Short-Term Seizure Remission Rates In Childhood Absence Epilepsy? 早期识别治疗失败和改变抗癫痫药物治疗方案能提高儿童缺席癫痫的短期发作缓解率吗?
Q3 Medicine Pub Date : 2020-06-01
Suresh Gurbani, Sirichai Chayasirisobhon, Aditya Gurbani, Noriko McCall

Purpose: To study the role of early serial EEGs in improving seizure freedom rates after initiation of ethosuximide or valproic acid for childhood absence epilepsy.

Methods: Retrospective data analysis study of AED naive patients with childhood absence epilepsy undergoing treatment at the community-based epilepsy clinic. Due to small sample size Fisher's exact test was used to determine two-tailed p value at less than 0.05 statistical significance..

Results: At 2-month study period 71.4% patients in the ethosuximide and 87.5% in the valproic acid group achieved seizure freedom, with EEG normalization in 21.4% and 50% respectively. At 6-month study period, in patients continuing ethosuximide, seizure freedom and EEG normalization rates were 89.5% and 52.6% respectively; while in patients continuing valproic acid, results were 100% and 78.6% respectively. Both at 2-month and 6-month study periods, a trend towards higher seizure freedom was noted in patients with typical versus non-typical epileptiform discharges at baseline with the valproic acid group showing a superior response.

Conclusion: Although no statistically significant difference in response rates was noted, 1) a shift towards higher seizure freedom with valproic acid; 2) improved response after switching to valproic acid at 2 months, if warranted; and 3) superior response rate in patients with typical EEG epileptiform discharges at baseline were observed. A larger study is needed to define the role of early serial EEGs to delineate higher drug failure probability; and to determine the importance of non-typical EEG characteristics at baseline in relation to the choice of AED and long-term outcome Keywords: childhood absence epilepsy, ethosuximide, valproic acid, non-typical epileptiform discharges.

目的:探讨早期连续脑电图对提高儿童缺席性癫痫患者应用乙氧亚胺或丙戊酸治疗后癫痫发作自由率的作用。方法:回顾性分析在社区癫痫门诊接受AED治疗的儿童缺失性癫痫患者的资料。由于样本量小,采用Fisher精确检验确定双尾p值,p值小于0.05。结果:在2个月的研究期间,乙氧亚胺组71.4%的患者癫痫发作自由,丙戊酸组87.5%的患者脑电图正常化,脑电图正常化率分别为21.4%和50%。在6个月的研究期间,持续使用埃索昔胺的患者癫痫发作自由率和脑电图正常化率分别为89.5%和52.6%;而在继续服用丙戊酸的患者中,结果分别为100%和78.6%。在2个月和6个月的研究期间,在基线时典型与非典型癫痫样放电的患者中发现了更高的癫痫发作自由的趋势,丙戊酸组表现出更好的反应。结论:虽然反应率没有统计学上的显著差异,但1)丙戊酸治疗的癫痫发作自由度更高;2)如果有必要,在2个月时改用丙戊酸后改善疗效;3)观察到基线时典型脑电图癫痫样放电患者的有效率更高。需要更大规模的研究来确定早期连续脑电图的作用,以描述更高的药物失败概率;并确定基线时非典型脑电图特征对AED选择和长期结局的重要性。关键词:儿童缺失性癫痫、乙氧亚胺、丙戊酸、非典型癫痫样放电。
{"title":"Does Early Recognition of Treatment Failure and Changing Anti-Epilepsy Medication Regimen Improve Short-Term Seizure Remission Rates In Childhood Absence Epilepsy?","authors":"Suresh Gurbani,&nbsp;Sirichai Chayasirisobhon,&nbsp;Aditya Gurbani,&nbsp;Noriko McCall","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To study the role of early serial EEGs in improving seizure freedom rates after initiation of ethosuximide or valproic acid for childhood absence epilepsy.</p><p><strong>Methods: </strong>Retrospective data analysis study of AED naive patients with childhood absence epilepsy undergoing treatment at the community-based epilepsy clinic. Due to small sample size Fisher's exact test was used to determine two-tailed p value at less than 0.05 statistical significance..</p><p><strong>Results: </strong>At 2-month study period 71.4% patients in the ethosuximide and 87.5% in the valproic acid group achieved seizure freedom, with EEG normalization in 21.4% and 50% respectively. At 6-month study period, in patients continuing ethosuximide, seizure freedom and EEG normalization rates were 89.5% and 52.6% respectively; while in patients continuing valproic acid, results were 100% and 78.6% respectively. Both at 2-month and 6-month study periods, a trend towards higher seizure freedom was noted in patients with typical versus non-typical epileptiform discharges at baseline with the valproic acid group showing a superior response.</p><p><strong>Conclusion: </strong>Although no statistically significant difference in response rates was noted, 1) a shift towards higher seizure freedom with valproic acid; 2) improved response after switching to valproic acid at 2 months, if warranted; and 3) superior response rate in patients with typical EEG epileptiform discharges at baseline were observed. A larger study is needed to define the role of early serial EEGs to delineate higher drug failure probability; and to determine the importance of non-typical EEG characteristics at baseline in relation to the choice of AED and long-term outcome Keywords: childhood absence epilepsy, ethosuximide, valproic acid, non-typical epileptiform discharges.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(2) ","pages":"46-53"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37959036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facial Artery Arteriovenous Malformation Endovascular and Surgical Treatment: Liquid Embolic Device an Advantage for Both Technique. 面动脉动静脉畸形血管内及手术治疗:液体栓塞装置是两种技术的优势。
Q3 Medicine Pub Date : 2020-06-01
Umberto G Rossi, Giuseppe Verrina, Anna Maria Ieradi, Mariangela Rutigliani, Maurizio Cariati

Facial ArterioVenous Malformations (AVM) are rare lesions and present great difficulty in their diagnosis and treatment. We report a case of a 24-year-old male who has been diagnosed a right facial AVM that underwent endovascular embolization with a liquid embolic device and consequently surgical resection. The type of liquid embolic device used has given advantage for both treatment techniques.

面部动静脉畸形(AVM)是一种罕见的病变,诊断和治疗都很困难。我们报告一个24岁男性的病例,他被诊断为右面部AVM,并接受了血管内液体栓塞装置栓塞和手术切除。所使用的液体栓塞装置的类型为两种治疗技术提供了优势。
{"title":"Facial Artery Arteriovenous Malformation Endovascular and Surgical Treatment: Liquid Embolic Device an Advantage for Both Technique.","authors":"Umberto G Rossi,&nbsp;Giuseppe Verrina,&nbsp;Anna Maria Ieradi,&nbsp;Mariangela Rutigliani,&nbsp;Maurizio Cariati","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Facial ArterioVenous Malformations (AVM) are rare lesions and present great difficulty in their diagnosis and treatment. We report a case of a 24-year-old male who has been diagnosed a right facial AVM that underwent endovascular embolization with a liquid embolic device and consequently surgical resection. The type of liquid embolic device used has given advantage for both treatment techniques.</p>","PeriodicalId":7102,"journal":{"name":"Acta neurologica Taiwanica","volume":"29(2) ","pages":"54-58"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37959037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta neurologica Taiwanica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1